|
|
Volumn 50, Issue 5 SUPPL. 5, 1998, Pages
|
|
Tolcapone: COMT inhibition for the treatment of Parkinson's disease
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMINE OXIDASE (FLAVIN CONTAINING);
AROMATIC LEVO AMINO ACID DECARBOXYLASE;
CATECHOL METHYLTRANSFERASE;
CATECHOL METHYLTRANSFERASE INHIBITOR;
DOPAMINE;
DOPAMINE RECEPTOR;
ENTACAPONE;
LEVODOPA;
TOLCAPONE;
CLINICAL TRIAL;
DAILY LIFE ACTIVITY;
DRUG ABSORPTION;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG METABOLISM;
DRUG SAFETY;
ENZYME INHIBITION;
HUMAN;
MOTOR PERFORMANCE;
NONHUMAN;
NOTE;
ORAL DRUG ADMINISTRATION;
PARKINSON DISEASE;
PRIORITY JOURNAL;
|
|
EID: 0031954731
PISSN: 00283878
EISSN: None
Source Type: Journal
DOI: 10.1212/wnl.50.5_suppl_5.s1 Document Type: Note |
|
Times cited : (15)
|
|
References (6)
|